B-type natriuretic peptide and Doppler echocardiography for identifying CHF patients at risk of acute heart failure decompensation during beta-blockade titration

被引：0
|
作者：
Ben Driss, A [1 ]
Tabet, JY [1 ]
Meurin, P [1 ]
Weber, H [1 ]
Renaud, N [1 ]
Grosdemouge, A [1 ]
Bourmayan, C [1 ]
机构：
[1] CRCB, Villenueve St Denis, France
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155A / 155A
页数：1
相关论文
共 50 条
  • [31] Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea
    Logeart, D
    Saudubray, C
    Beyne, P
    Thabut, G
    Ennezat, PV
    Chavelas, C
    Zanker, C
    Bouvier, E
    Solal, AC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) : 1794 - 1800
  • [32] Prognostic significance of B-type natriuretic peptide and pulmonary arterial pressure in patients with acute heart failure
    Petrovic, D.
    Ilic, M. Deljanin
    Ilic, S.
    Stojanovic, S.
    Marinkovic, D.
    Simonovic, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 392 - 393
  • [33] Prognostic Role of Molecular Forms of B-Type Natriuretic Peptide in Acute Heart Failure
    Suzuki, Toru
    Israr, M. Zubair
    Heaney, Liam M.
    Takaoka, Minoru
    Squire, Lain B.
    Ng, Leong L.
    CLINICAL CHEMISTRY, 2017, 63 (04) : 880 - 886
  • [34] Early B-type natriuretic peptide response predicts outcome in acute heart failure
    不详
    BIOMARKERS IN MEDICINE, 2009, 3 (04) : 342 - 342
  • [35] B-type natriuretic peptide and acute heart failure: Fluid homeostasis, biomarker and therapeutics
    Torres-Courchoud, I.
    Chen, H. H.
    REVISTA CLINICA ESPANOLA, 2016, 216 (07): : 393 - 398
  • [36] Clinical significance of B-type natriuretic peptide in patient with acute decompensated heart failure
    Izumida, Toshihide
    Imamura, Teruhiko
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 329 : 152 - 152
  • [37] B-type natriuretic peptide as a risk predictor of long-term outcomes in heart failure patients
    HCV Rey
    MI Bittencourt
    RM Rocha
    FOD Rangel
    ALC Marins
    MI Garcia
    SS Xavier
    R Esporcatte
    Critical Care, 9 (Suppl 2):
  • [38] Is B-type Natriuretic Peptide a Risk Factor for Heart Failure in Patients Treated With Bardoxolone Methyl? Reply
    Chin, Melanie P.
    Meyer, Colin J.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (03) : 259 - 259
  • [39] Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
    Logeart, D
    Thabut, G
    Jourdain, P
    Chavelas, C
    Beyne, P
    Beauvais, F
    Bouvier, E
    Solal, AC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 635 - 641
  • [40] Nonterminal pro B-type natriuretic peptide in patients with chronic heart failure: Correlation with B-type natriuretic peptide and left ventricular structure and function
    Mitrovic, V
    Anand, I
    Dill, T
    Weber, M
    Notter, T
    Schenk, J
    Luescher, TF
    Hamm, CW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 235A - 235A
12345